# A Study to Evaluate the Efficacy and Safety of Vedolizumab in the Treatment of Chronic Pouchitis

> **NCT02790138** · PHASE4 · COMPLETED · sponsor: **Takeda** · enrollment: 102 (actual)

## Conditions studied

- Pouchitis

## Interventions

- **DRUG:** Vedolizumab Placebo
- **DRUG:** Ciprofloxacin
- **DRUG:** Vedolizumab

## Key facts

- **NCT ID:** NCT02790138
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10-12
- **Primary completion:** 2020-06-11
- **Final completion:** 2021-02-02
- **Target enrollment:** 102 (ACTUAL)
- **Last updated:** 2022-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02790138

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02790138, "A Study to Evaluate the Efficacy and Safety of Vedolizumab in the Treatment of Chronic Pouchitis". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT02790138. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*